DANG NGUYEN: Open Payments
NPI 1932470788 · GARDEN GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 34 payments from 15 companies in 2025. Trend: 2023 $1,674 · 2024 $1,808 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $98 |
| Lilly USA, LLC | 2 | $50 |
| Intra-Sana Laboratories | 1 | $35 |
| Insulet Corporation | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: EVENITY, Kerendia, JARDIANCE, RELTONE 200 MG, REPATHA, OTEZLA, Omnipod, REXULTI.
Industry payments across CA — which companies pay providers there.
